HealthEquity’s (HQY) “Outperform” Rating Reiterated at Royal Bank of Canada

Royal Bank of Canada reaffirmed their outperform rating on shares of HealthEquity (NASDAQ:HQY) in a report released on Wednesday morning, Benzinga reports. Royal Bank of Canada currently has a $92.00 target price on the stock.

HQY has been the topic of a number of other research reports. JMP Securities increased their target price on shares of HealthEquity from $101.00 to $105.00 and gave the stock a market outperform rating in a research report on Tuesday, June 4th. Bank of America lowered their price objective on HealthEquity from $105.00 to $100.00 and set a buy rating on the stock in a research note on Wednesday. KeyCorp upped their target price on HealthEquity from $95.00 to $100.00 and gave the company an overweight rating in a research report on Wednesday, June 5th. Robert W. Baird raised their price target on HealthEquity from $98.00 to $104.00 and gave the stock an outperform rating in a research report on Tuesday, June 4th. Finally, Raymond James upped their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the stock an outperform rating in a research report on Friday, June 7th. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of Moderate Buy and an average price target of $103.83.

HealthEquity Trading Down 4.1 %

Shares of HealthEquity stock opened at $76.24 on Wednesday. The company has a debt-to-equity ratio of 0.44, a quick ratio of 4.39 and a current ratio of 4.39. The firm has a 50-day moving average of $77.03 and a 200-day moving average of $79.66. HealthEquity has a 52-week low of $61.81 and a 52-week high of $88.26. The stock has a market cap of $6.63 billion, a PE ratio of 82.87, a PEG ratio of 1.34 and a beta of 0.52.

Insider Buying and Selling

In other HealthEquity news, Vice Chairman Stephen Neeleman sold 35,000 shares of the firm’s stock in a transaction that occurred on Thursday, July 25th. The shares were sold at an average price of $79.86, for a total value of $2,795,100.00. Following the sale, the insider now owns 89,769 shares in the company, valued at $7,168,952.34. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In related news, Director Frank Corvino sold 7,705 shares of the firm’s stock in a transaction that occurred on Monday, July 8th. The shares were sold at an average price of $81.89, for a total value of $630,962.45. Following the completion of the transaction, the director now owns 6,070 shares in the company, valued at approximately $497,072.30. The sale was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Vice Chairman Stephen Neeleman sold 35,000 shares of the business’s stock in a transaction that occurred on Thursday, July 25th. The stock was sold at an average price of $79.86, for a total transaction of $2,795,100.00. Following the sale, the insider now directly owns 89,769 shares in the company, valued at $7,168,952.34. The disclosure for this sale can be found here. Insiders sold a total of 75,031 shares of company stock worth $6,103,625 in the last three months. 2.20% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On HealthEquity

Hedge funds have recently modified their holdings of the business. Cape Investment Advisory Inc. bought a new position in HealthEquity during the 4th quarter worth $27,000. Rise Advisors LLC bought a new position in shares of HealthEquity during the first quarter worth about $28,000. International Assets Investment Management LLC acquired a new position in shares of HealthEquity in the second quarter worth approximately $35,000. YHB Investment Advisors Inc. acquired a new position in shares of HealthEquity in the first quarter worth approximately $40,000. Finally, Fidelis Capital Partners LLC bought a new stake in HealthEquity in the first quarter valued at approximately $42,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.